AstraZeneca tries to reassure public after recent COVID vaccine safety concerns
Fox News
AstraZeneca issued a statement on Monday defending its COVID-19 vaccine after some countries raised concerns about blood clots in vaccine recipients and called for a temporary suspension.
Ireland announced Sunday that it would temporarily suspend distributing the vaccine "out of an abundance of caution," Reuters reported. The move was announced after reports of blood clotting in some of the recipients in Norway. AstraZeneca, the Cambridge, U.K., company, said more than 17 million people have been vaccinated with the shots in the European Union and the United Kingdom, and there has been "no evidence of an increased risk of pulmonary embolism, deep vein thrombosis or thrombocytopenia, in any defined age group, gender, batch or any particular country." The statement pointed to cases of pulmonary embolisms and said the number of these cases after receiving the shot are "much lower than would be expected to occur naturally in a general population of this size and is similar across other licensed COVID-19 vaccines."More Related News
American Culture Quiz: Test yourself on groundbreaking gadgets, medical marvels and Southern staples
The American Culture Quiz is a weekly test of our unique national traits, trends, history and people. This time, test your knowledge of groundbreaking gadgets, medical marvels and more.